Please login to the form below

anti-infectives

This page shows the latest anti-infectives news and features for those working in and with pharma, biotech and healthcare.

UK-based ADVANZ PHARMA has a strategic focus on complex medicines in Europe, with expertise in anti-infectives and endocrinology therapy areas.

IFPMA launches AMR Action Fund to tackle antimicrobial resistance

Pfizer is one of the few large, research-based pharmaceutical companies that are still active in research and development for anti-infectives.
UK unveils new antibiotic buying plan, pharma incentives

The answer is to develop a new economic model for antibiotic development that doesn’t tie revenue to volume, as new anti-infectives generally need to be conserved.
Ex-Pharmacyclics CEO invests $25m in Summit

After Duchenne drug failure, UK biotech looks to new anti-infective. US biotech billionaire Bob Duggan is to invest $25m into antibiotics developer Summit Therapeutics, taking a near-49% stake in ... It’s also a boost to the UK company after the
Novartis culls pipeline to focus on most transformative science

Anti-infectives among areas hit by streamlining. Novartis has revealed that it is to abandon over 100 R&D programmes, slashing its pipeline by a fifth. ... It recently hit problems with one of its most important late-stage programmes when the FDA refused
Novo Nordisk and Evotec inks drug development deal

Will develop drugs for obesity and diabetes. Just two months after it bought French pharma Sanofi’s anti-infectives unit, Evotec has penned a new deal, this time with Danish firm

More from news
Approximately 4 fully matching, plus 52 partially matching documents found.

Rebranding in an evolving world

This includes advancements in some of our key therapy areas that we believe will be of great value to patients, particularly in the anti-infectives space which has had limited investment
30 Women Leaders in UK Healthcare (part 3)

An immunologist with over two decades’ experience in anti-infectives research and drug development, Deborah set up Novabiotic Pharmaceuticals to discover and develop the next generation of treatments.
Deal Watch May 2016

Not only but also…. To close this month a recent report from the UK government expresses concerns about the lack of investment in anti-infectives R&D.
Another lost decade for research?

use but new classes of antibiotics - as well as non-antibiotic approaches such as other anti-infective treatments. ... Over the past 10 years the number of patent families filed in the antibiotics and anti-infectives field has remained stable, with
Pharma deals in June 2015

CNS, diabetes, respiratory, vaccines and anti-infectives, oncology and autoimmune diseases. ... The consequences of acquisitions. One of the consequences of M&A is the need to assess a newly combined portfolio for potential anti-competitive issues.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Damien McDevitt moves from GSK to Acadia Pharmaceuticals

Prior to that, McDevitt held positions with increasing responsibility within worldwide business development at GSK Ventures and Anti-Infectives Discovery.
Nabriva Therapeutics appoints new chief commercial officer

Lavino joins the Austrian clinical-stage biopharma firm from Merck &Co (MSD), bringing nearly two decades of pharmaceutical sales and marketing experience with expertise in anti-infective medications. ... Prior to serving MSD as its acting vice president,
Cidara Therapeutics makes senior appointments

Prior to BMS, Daruwala spent 18 years at Merck in a range of US and global commercial leadership roles in areas including anti-inflammatory products, business development and sales management. ... Cidara focuses on the discovery, development and
Xellia forms scientific advisory board

Will further progress on innovative anti-infectives. Xellia Pharmaceuticals, who have a focus on anti-infective treatments, has announced the formation of a new scientific advisory board.
Melinta names chief medical officer

She has prior experience in developing anti-infectives, including Cubicin (daptomycin) during her time at Novartis, where she served as VP and global programme head for the company's immunology and ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

NovaBiotics Ltd, the clinical-stage anti-infectives biotechnology company, today announced that it has entered into a licensing agreement with an undisclosed partner to commercialise its NP213 peptide in a topical
SENIOR PHARMA MARKETER JOINS CELLO HEALTH CONSULTING

He joined the company as Director of Early Phase Commercial Development, before heading up Astellas’ European marketing team for Anti-Infectives.
SEVEN STONES COLLECTIVE

Branding. Digital and tech solutions. Exercise co-prescription. Workplace wellbeing. Experience. Anti-infectives, cardiovascular, contrast media, dermatology, diabetes, diagnostics, gastroenterology, gene therapy, health and fitness, hepatology,

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Country Manager, Healthcare Communications Agency, Germany: Highly competitive salary

Add my company

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

The communication challenge of helping he next generation to be healthier: As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?: We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
How the Royal Society’s EiR programme can help to drive UK innovation: ...

Email:
Password: